Bronchospasm: Definition, Symptoms, Causes, and Treatment
(definition) is defined as constriction of bronchi and
bronchioles. It can generally happen due to 3 factors:
- a spasm in the smooth muscles of bronchi and bronchioles
- an inflammation of the airways
- excessive production of sputum (mucus) due to an allergic reaction or possible irritation caused by mechanical friction of air (due to shear stress), overcooling or drying of airways (i.e., during exercise induced asthma).
Bronchospasm is a normal physiological reaction to alveolar hyperventilation (Badier et al, 1998; Clarke et al, 1982; Jamison et al, 1987; O'Cain et al, 1979; Sterling, 1968), as you can see from the titles of these articles (see below). Do people with bronchitis, asthma, and other conditions suffer from alveolar hypocapnia (CO2 deficiency in airways)? What is known about minute ventilation in people with bronchospasm?
Ventilation rates (chronic diseases)
| All references or
click below for abstracts
|Normal breathing||6 L/min||-||Medical textbooks|
|Healthy Subjects||6-7 L/min||>400||Results of 14 studies|
|Asthma||13 (+-2) L/min||16||Chalupa et al, 2004|
|Asthma||15 L/min||8||Johnson et al, 1995|
|Asthma||14 (+-6) L/min||39||Bowler et al, 1998|
|Asthma||13 (+-4) L/min||17||Kassabian et al, 1982|
|Asthma||12 L/min||101||McFadden, Lyons, 1968|
|COPD||14 (+-2) L/min||12||Palange et al, 2001|
|COPD||12 (+-2) L/min||10||Sinderby et al, 2001|
|COPD||14 L/min||3||Stulbarg et al, 2001|
|Cystic fibrosis||15 L/min||15||Fauroux et al, 2006|
|Cystic fibrosis||10 L/min||11||Browning et al, 1990|
|Cystic fibrosis*||10 L/min||10||Ward et al, 1999|
|CF and diabetes*||10 L/min||7||Ward et al, 1999|
|Cystic fibrosis||16 L/min||7||Dodd et al, 2006|
|Cystic fibrosis||18 L/min||9||McKone et al, 2005|
|Cystic fibrosis*||13 (+-2) L/min||10||Bell et al, 1996|
|Cystic fibrosis||11-14 L/min||6||Tepper et al, 1983|
Bronchospasm can be induced by many chemicals that can cause either bronchoconstriction or bronchodilation, but CO2 plays the key role due to two factors: its vasodilatory potency (see links with medical studies below) and additional negative effects caused by alveolar hypocapnia (lack of CO2), as the Table above proves.
What else influences bronchospasm?
Chronic hyperventilation (breathing more air than the medical norm) also leads to cell hypoxia and immunosuppression regardless of ventilation-perfusion ratio and arterial CO2 levels (it can get too high for many lung pathologies). As a result of alveolar hyperventilation, there are additional effects, such as frequent respiratory infections, excessive production of sputum (mucus) and chronic inflammation. Allergic triggers (dust, pollen, and many others) cause additional problems due to the hypersensitive immune system caused by systemic body hypoxia. All these factors narrow airways and worsen their conductivity, triggering bronchospasm.
Symptoms of bronchospasm
Bronchospasm symptoms include difficulty breathing, wheezing, coughing, and dyspnea (shortness of breath). Increased respiratory ventilation drastically amplifies the effects of bronchospasm.
Causes and mechanism of bronchospasm
Bronchospasm mechanism follows from the above Table, which shows that these groups of people are heavy breathers. They all have low CO2 levels in their lungs. As a result of low alveolar CO2, they also have low body-oxygen levels due to effects of alveolar hypocapnia, which either destroys lungs (causing arterial hypercapnia and hypoxemia as for people with COPD) or causes arterial hypocapnia with reduced oxygen transport, as an additional factor that is present during bronchospasm.
Bronchospasm, therefore, due to its effects on oxygen transport, leads to low oxygen levels in tissues and favors chronic inflammation (see links below). As a result, people with lung conditions (asthma, bronchitis, bronchiestasis, bronchiolitis, cystic fibrosis, tuberculosis, sarcoidosis, and many others), experience chronic bronchospasm in the smooth muscles of airways due to chronic alveolar hypocapnia.
This YouTube video explains the cause of bronchospasm.
Surgery of the throat or anesthesia can also be among some rare bronchospasm causes.
Treatment of bronchospasm
Bronchospasm can be successfully treated, as over 180 Russian medical doctors, found. The effective way to deal with bronchoconstriction is the Buteyko breathing medical therapy that is approved by the Russian Ministry of Health. It has been applied on more than 200,000 people with health problems (such as asthma, bronchiestasis, bronchiolitis, bronchitis, COPD, and many others) that involve bronchospasm.
Bronchospasm cure (clinical remission), according to these Russian medical doctors, has simple criteria. The patient needs to achieve more than 20 seconds for the body-oxygen test in order to prevent symptoms of bronchospasm at rest. Healing of airways is possible when automatic breathing parameters are nearly normal (more than 40 seconds for the body-oxygen levels 24/7). Physical exercise with nose breathing is a very beneficial lifestyle factor that assists breathing retraining and gradual increase in body oxygen stores. Nose breathing at exercise prevents exercise-induced asthma and bronchospasm.
Bronchospasm symptoms can be effectively eliminated with breathing exercises that involve those breathing devices that trap exhaled CO2 (such as the Amazing DIY breathing device, Frolov breathing device, and Samozdrav). These devices help to increase body-oxygen levels and reduce bronchospasm in a matter of minutes. However, up to 2-4 weeks are often necessary in order to significantly change automatic or basal breathing patterns. Any bronchospasm treatment must also address lifestyle changes (prevention of supine sleep, prevention of mouth breathing, and so forth). The best lifestyle program can be found in the Buteyko technique. Oxygen Remedy online webinars is likely the easiest way to achieve clinical remission in relation to bronchospasm.
Badier M, Beaumont D, Orehek J, Attenuation of hyperventilation-induced
bronchospasm by terfenadine: a new antihistamine, J Allergy Clin Immunol.
Clarke PS, Jarrett RG, Hall GJ, The protective effect of ipratropium bromide aerosol against bronchospasm induced by hyperventilation and the inhalation of allergen, methacholine and histamine, Ann Allergy. 1982 Mar;48(3):180-3.
Jamison JP, Glover PJ, Wallace WF, Comparison of the effects of inhaled
ipratropium bromide and salbutamol on the bronchoconstrictor response to
hypocapnic hyperventilation in normal subjects, Thorax. 1987 Oct; 42(10):
....This suggests that bronchoconstriction in response to hypocapnic hyperventilation in normal subjects is not mediated via a cholinergic reflex.
O'Cain CF, Hensley MJ, McFadden ER Jr, Ingram RH Jr, Pattern and mechanism of airway response to hypocapnia in normal subjects, J Appl Physiol. 1979 Jul;47(1):8-12.
We examined the bronchoconstriction produced by airway hypocapnia in normal subjects... Pretreatment with a beta-sympathomimetic agent blocked the response, whereas atropine pretreatment did not, suggesting that hypocapnia affects airway smooth muscle directly, not via cholinergic efferents.
Reynolds AM, McEvoy RD, Tachykinins mediate hypocapnia-induced
bronchoconstriction in guinea pigs, J Appl Physiol. 1989
... We conclude that, in the guinea pig lung, HIBC [hypocapnia-induced bronchoconstriction] is mediated by TKs [tachykinins] that are released after the activation of bronchial axonal reflexes.
Sterling GM, The mechanism of bronchoconstriction due to hypocapnia in man, Clinical Science 1968 Apr; 34(2): p. 277-285.
Straub NC, Section V, The Respiratory System, in Physiology, edited by. Berne RM & Levy MN, 4th edition, Mosby, St. Louis, 1998.
* Upper left illustration by Victor Lunn-Rockliffe
Go back to Breathing Techniques
You can leave your feedback and comments below. Thanks.
|Disclaimer||Copyright 2014 Artour Rakhimov||Contact details|